The abstract is read at the publisher; the summary is JClub's.
Cers6 is selectively upregulated in thoracic aortic perivascular adipose tissue of β-aminopropionitrile/AngII aortic dissection mice, driving higher C16:0 ceramide levels.
- Why it matters: PVAT is a key local endocrine niche, but how Cers6/C16:0 ceramide in taPVAT contributes to aortic dissection and macrophage-driven inflammation was unclear.
- What they did: The study used proteomics and quantitative lipidomics of taPVAT, locally manipulated Cers6 with adeno-associated virus, and tested exogenous C16:0 ceramide in vivo and in adipocyte–BMDM coculture. Mechanisms were probed with transcriptomics plus Fpr2/NF-κB pathway tools, including WRW4.
- The result: Cers6 knockdown or WRW4 reduced AD incidence, ECM degradation, and inflammation, while Cers6 overexpression or C16:0 ceramide increased macrophage inflammatory activation, migration, and Mmp9 via Fpr2/NF-κB; human taPVAT showed higher CERS6/C16:0 ceramide linked to inflammatory gene expression and maximal thoracic aortic diameter.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.